Understanding the link between immune cell function and lung function in the development of asthma in early life

Asthma affects one in eight children in Australia and is the leading cause of hospitalisations and emergency visits, with an estimated annual health care cost of more than 24 billion Australian dollars in 2015. Asthma is the most common medical complication in pregnancy and is strongly associated with the development of childhood asthma. ntion strategy for asthma.

Re-purposing PARP inhibitors to treat childhood leukaemias

Cancer is the most common cause of childhood disease-related deaths, with leukaemia the most common childhood cancer in Australia. The two most common forms of leukaemia in children are acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). Whilst remission is achievable in over 95% of ALL cases, 1/3 of patients will relapse within 5 to 10 years, and these children will not be long-term survivors. AML accounts for 20% of all childhood leukaemias, and the outlook for children diagnosed with AML is much worse, with only approximately half of children surviving for 5 years post-diagnosis.

Development and pilot study of an evidence-based internet intervention to improve symptoms, functioning and health-related quality of life in children with functional abdominal pain

Cognitive-Behaviour Therapy, or CBT, is one of the few effective therapies for children with functional abdominal pain. But CBT sessions can be costly and difficult to access, particularly as multiple sessions are required.

Prader-Willi Syndrome

HCRF has funded Dr Komal Vora’s study into Prader-Willi Syndrome – a complex genetic disorder that affects development and growth of the child, manifesting as cognitive disability, obesity, short stature and a chronic feeling of hunger.

The role of microbiome development in the early origins of asthma in a high risk population

Children born to mothers with asthma are three times more likely to develop asthma themselves than those with asthmatic fathers, which suggests that a risk factor extends beyond genetics. There is emerging evidence that bacteria in the infant’s gut can impact immune function and contribute to the types of immune responses that are seen in asthma.